RECENSA THERAPEUTICS
Recensa is developing small molecules that activate the transcription factor Nrf2, a key modulator of antioxidant response. These molecules will be embedded in topical vehicles-such as creams or lotions-and will be tested in animal models of psoriasis so we can gain FDA approval for human clinical trials. Future products may target other diseases where oxidative stress is a key factor
RECENSA THERAPEUTICS
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2016-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.recensatherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
77 K USD
Technology used in webpage:
SPF Namecheap DNS Namecheap Hosting Namecheap
Similar Organizations
Black Belt Therapeutics
Black Belt Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Cystinosis Research Foundation
Cystinosis Research Foundation supports bench, clinical, and translational research to find therapeutics for cystinosis.
Decedario
Decedario is a therapeutic board game for cognitive stimulation.
DNAdigest
DNAdigest is a scientific social enterprise that enables the secure sharing and query of genomics data for research.
Genome Explorations
Genome Explorations is a research institution that provides global genomic profiling and molecular diagnostics services.
Gentec
Gentec managed to create things like the first private laboratory to do a genetic edition using CRISPR-Cas9 technology in Mexico.
M. STEVES USA
Products that Perform beautyfully to visibly improve skin
PSMA Therapeutics
PSMA Therapeutics is a subsidiary of Noria to advance the platform of prostate-specific membrane antigen (PSMA) targeting radiotherapeutics.
Ventrinova
VentriNova is revolutionizing cardiac regenerative medicine by reversing cardiac damage pharmacologically.
Current Employees Featured
Founder
Investors List
Phase 1 Ventures
Phase 1 Ventures investment in Pre Seed Round - Recensa Therapeutics
Phase One Ventures
Phase One Ventures investment in Pre Seed Round - Recensa Therapeutics
Phase 1 Ventures
Phase 1 Ventures investment in Pre Seed Round - Recensa Therapeutics
Official Site Inspections
http://www.recensatherapeutics.com
Unable to get host informations!!!
More informations about "Recensa Therapeutics"
Recensa Therapeutics - Crunchbase Company Profile
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress. Recensa is developing small molecules that activate the transcription factor Nrf2, a key modulator of antioxidant response.See details»
Recensa Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Recensa Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Recensa Therapeutics - Craft
Recensa Therapeutics is a company offering an approach to treat psoriasis. It develops Nrf2 Activators that leverage the body’s own antioxidants to stop the inflammatory cycle. See …See details»
Recensa Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Recensa Therapeutics, Inc. of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
Recensa Therapeutics - Products, Competitors, Financials, …
Jun 13, 2017 · Recensa Therapeutics screens for molecules that stimulate the body's anti-oxidant response against inflammation. Recensa is using this technology to develop topical therapies …See details»
Recensa Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Recensa Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Recensa Therapeutics - Overview, News & Similar companies
View Recensa Therapeutics (www.recensatherapeutics.com) location in Delaware, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Recensa Therapeutics - Funding, Financials, Valuation & Investors
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.See details»
Recensa Therapeutics - Overview, Competitors, and Employees
View Recensa Therapeutics (http://www.recensatherapeutics.com) location in Pennsylvania, United States, revenue, competitors and contact information. Find and reach Recensa …See details»
Recensa Therapeutics - Crunchbase
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.See details»
Establishing a Better Microbiome for Better Health - Seres …
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Discover our progress.See details»
Home - NextRNA
We identify tissue-specific and disease-driving lncRNAs across therapeutic areas. We validate the role of lncRNAs and characterize lncRNA-RBP interactions driving the mechanism of action in …See details»
RNA-based therapeutics: an overview and prospectus
Jul 23, 2022 · In this review, the mechanisms of action, challenges, solutions, and clinical application of RNA-based therapeutics have been comprehensively summarized. Small …See details»
Messenger RNA-Based Therapeutics and Vaccines: What’s beyond …
Jul 4, 2023 · Here, based on the CAS Content Collection, we provide a landscape view of the current state, outline trends in the research and development of mRNA therapeutics and …See details»
Recensa Therapeutics - Contacts, Employees, Board Members
Recensa Therapeutics has 1 current employee profile, Co founder Oscar Perez-Leal. Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.See details»
Certa Therapeutics – Developing innovative precision therapies for ...
Our mission is to be a world class anti-fibrotic company by developing innovative, targeted therapeutics to treat serious, often life-threatening fibrotic diseases including scleroderma, …See details»
Quito Mujer - CONQUITO
La convocatoria «Quito Mujer» tiene como objetivo convocar, evaluar, seleccionar y otorgar fondos de capital semilla a emprendimientos liderados por mujeres con potencial dinámico. …See details»
Progenra - Progenra
Progenra’s mission is to leverage its expertise in the ubiquitin proteasome system, Molecular Glues and, PROTAC drugs to discover and develop novel, first in class medicines to fill unmet …See details»
Recensa Therapeutics - Tech Stack, Apps, Patents & Trademarks
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.See details»
Homepage - Centessa Pharmaceuticals
We’re pursuing our LockBody® Technology Platform with the aim to redefine immuno-oncology treatment for patients with cancer. Patient-Centric Mission. Asset-Centric Approach.See details»